Literature DB >> 1827740

Lipoprotein (a) levels do not influence the outcome of rt-PA therapy in acute myocardial infarction.

B Tranchesi, R Santos Filho, C Vinagre, B Caramelli, V Barbosa, O Gebara, G Belloti, F Pileggi, R Maranhão.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1827740     DOI： 10.1007/bf01702928

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  9 in total

1.  Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator.

Authors:  J M Edelberg; M Gonzalez-Gronow; S V Pizzo
Journal:  Thromb Res       Date:  1990-01-01       Impact factor: 3.944

2.  Lipoprotein (a) and plasminogen are immunochemically related.

Authors:  I Karàdi; G M Kostner; A Gries; J Nimpf; L Romics; E Malle
Journal:  Biochim Biophys Acta       Date:  1988-05-02

3.  Transient changes of serum lipoprotein(a) as an acute phase protein.

Authors:  S Maeda; A Abe; M Seishima; K Makino; A Noma; M Kawade
Journal:  Atherosclerosis       Date:  1989-08       Impact factor: 5.162

4.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen.

Authors:  J W McLean; J E Tomlinson; W J Kuang; D L Eaton; E Y Chen; G M Fless; A M Scanu; R M Lawn
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

5.  Plasma lipoproteins: teaching old dogmas new tricks.

Authors:  M S Brown; J L Goldstein
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

Review 6.  The mysteries of lipoprotein(a).

Authors:  G Utermann
Journal:  Science       Date:  1989-11-17       Impact factor: 47.728

7.  A potential basis for the thrombotic risks associated with lipoprotein(a).

Authors:  L A Miles; G M Fless; E G Levin; A M Scanu; E F Plow
Journal:  Nature       Date:  1989-05-25       Impact factor: 49.962

8.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors:  J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

9.  Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

Authors:  A Hamsten; U de Faire; G Walldius; G Dahlén; A Szamosi; C Landou; M Blombäck; B Wiman
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.